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1. 利用基于 NMR 代谢组学方法研究糖尿病。分别获得动物模型和人类的血
液、尿液的 NMR 谱，结合模式识别分析方法，得到相关的特征代谢物，并建立





3. 结合大量文献，对基于 NMR 的代谢组学应用于糖尿病的研究进展做一简
要综述，并对后续研究加以展望。 
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With the improvement of people's standard of living and lifestyle changes, the 
incidence of diabetes showed increasing year by year, the trend has been more and 
more people's attention. However, because diabetes is a metabolic disorder as a whole 
which involved multiple factors, the regulation mechanism is very complicated. 
Current research methods neglected dynamic metabolic changes of organ in the 
overall，and can not provide the overall cell function information. Therefore, it is 
necessary to find a new way to get biomedical information of diabetes in organisms as 
a whole, metabonomic approach which can get overall information from systematic 
perspective provides a good technology platform for the study. 
As a non-invasive and efficient means of detection, NMR (nuclear magnetic 
resonance) technology is commonly used metabonomic methods. The NMR-based 
metabonomic approach has been widely used in biofluids research. The aim of this 
paper is to find characteristic metabolites of diabetes, analyse the toxicity of 
vanadium compounds by NMR-based metabonomic approach, and explore the 
possibility of methods used in diabetes research. The main contents of this study are 
as follows: 
First, by NMR-based metabonomic approach, obtaining NMR spectrum of 
blood, urine from animal model and human; finding characteristic metabolites of 
diabetes with pattern recognition analysis, and building experimental research 
methods of NMR-based metabonomics . 
Second, on the basis of inspecting hypoglycemic effect of vanadium 
compounds , analyzing toxicity of VOSO4 by NMR-based metabonomic approach, 
understanding toxic effects of vanadium compounds, and deepening the 
understanding of vanadium compounds. 
Third, with substantive literature, making a brief overview of NMR-based 














In short, NMR-based metabonomics approach can be used for the distinction 
between diabetes and normal control, and drug toxicity analysis, it is an effective way 
to find characteristic biomarker and will have a broad prospects of development in the 
diagnosis, pathological research of diabetes in the future. 
 














第一章  绪    论 
1.1  糖尿病简介 
糖尿病（diabetes mellitus，DM）[ ]1 是一种以糖代谢失常为主的常见内分泌
代谢性疾病。人类对糖尿病的认识始于公元 1500 年前，2 世纪时有称为“口渴、
糖多病”，希腊语称“diabets”，意为多尿症。17 世纪英国查理士二世的保健医师
发现患者的尿甜如蜜，称为流出甜尿病，由此而得名糖尿病。 
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